Emerald Mutual Fund Advisers Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-832
Closed -$121K 235
2020
Q3
$121K Sell
832
-15
-2% -$2.13K 0.01% 254
2020
Q2
$125K Buy
+847
New +$114K 0.01% 248
2020
Q1
Sell
-1,002
Closed -$115K 224
2019
Q4
$115K Buy
+1,002
New +$99.9K ﹤0.01% 219
2015
Q2
Sell
-3,964
Closed -$415K 256
2015
Q1
$415K Sell
3,964
-162,404
-98% -$16.5M 0.03% 198
2014
Q4
$16.1M Sell
166,368
-45,319
-21% -$4.2M 1.4% 13
2014
Q3
$16.5M Sell
211,687
-10,914
-5% -$704K 1.58% 8
2014
Q2
$14.1M Buy
222,601
+9,640
+5% +$573K 1.29% 16
2014
Q1
$14.3M Sell
212,961
-141,711
-40% -$11M 1.37% 11
2013
Q4
$26.4M Buy
354,672
+124,595
+54% +$7.43M 1.57% 9
2013
Q3
$14.7M Buy
230,077
+15,440
+7% +$770K 2.03% 4
2013
Q2
$6.65M Buy
+214,637
New +$5.71M 1.13% 28

Other funds holding ALNY